References
- Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 2013; 39:38 - 48; http://dx.doi.org/10.1016/j.immuni.2013.07.004; PMID: 23890062
- Schuler G. Dendritic cells in cancer immunotherapy. Eur J Immunol 2010; 40:2123 - 30; http://dx.doi.org/10.1002/eji.201040630; PMID: 20853498
- Gogolak P, Rethi B, Szatmari I, Lanyi A, Dezso B, Nagy L, Rajnavolgyi E. Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood 2007; 109:643 - 52; http://dx.doi.org/10.1182/blood-2006-04-016840; PMID: 16968896
- Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka AK, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008; 29:497 - 510; http://dx.doi.org/10.1016/j.immuni.2008.07.013; PMID: 18789730
- Nasi A, Fekete T, Krishnamurthy A, Snowden S, Rajnavölgyi E, Catrina AI, Wheelock CE, Vivar N, Rethi B. Dendritic cell reprogramming by endogenously produced lactic Acid. J Immunol 2013; 191:3090 - 9; http://dx.doi.org/10.4049/jimmunol.1300772; PMID: 23956421
- Gottfried E, Kunz-Schughart LA, Ebner S, Mueller-Klieser W, Hoves S, Andreesen R, Mackensen A, Kreutz M. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 2006; 107:2013 - 21; http://dx.doi.org/10.1182/blood-2005-05-1795; PMID: 16278308